BOSTON SCIENTIFIC CORP vs Intuitive Surgical, Inc., two Medical Devices stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where BSX and ISRG diverge most: on p/s, BSX reads 3.39 and ISRG reads 11.44; on ev/ebitda, BSX reads 13.2 and ISRG reads 35.8. The rest of the comparable metrics sit closer together. What BSX's price implies is a bet that sits within the historical range (whole-company basis). What ISRG's price implies is a demanding bet versus history and the cohort (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | BSX | ISRG |
|---|---|---|
| Price | $46.73 | $353.34 |
| Market cap | $69.9B | $126.2B |
| Sector | Medical Devices | Medical Devices |
| Stage | Growth | Growth |
| Implied growth (priced in) | +8.9% | — |
| P/E | 19.6 | 40.6 |
| P/B | 2.68 | 6.90 |
| P/S | 3.39 | 11.44 |
| EV/EBITDA | 13.2 | 35.8 |
| Revenue growth | +17.6% | +20.8% |
| Gross margin | 69.5% | 67.8% |
| Operating margin | 21.2% | 33.6% |
| Net margin | 17.3% | 28.4% |
| Return on equity | 13.6% | 17.1% |
| Return on assets | 8.0% | 15.0% |
| Return on invested capital | 11.5% | 14.7% |
| FCF yield | 5.0% | 2.5% |
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 1.90 | 4.96 |
| Altman Z (solvency) | 6.88 | 7.58 |
| Piotroski F (quality) | 5 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.